Cover Image
市場調查報告書

德國的藥物輸送設備市場未來展望:中央靜脈導管,輸液系統,無針頭注射器,定量噴霧吸入器 (MDI)

Germany Drug Delivery Devices Market Outlook to 2023 - Central Venous Catheters, Infusion Systems, Needle Free Injections and Metered Dose Inhaler Devices

出版商 GlobalData 商品編碼 537206
出版日期 內容資訊 英文 162 Pages
訂單完成後即時交付
價格
Back to Top
德國的藥物輸送設備市場未來展望:中央靜脈導管,輸液系統,無針頭注射器,定量噴霧吸入器 (MDI) Germany Drug Delivery Devices Market Outlook to 2023 - Central Venous Catheters, Infusion Systems, Needle Free Injections and Metered Dose Inhaler Devices
出版日期: 2017年08月01日 內容資訊: 英文 162 Pages
簡介

本報告提供德國的各種的藥物輸送設備的市場相關分析,整體市場趨勢的轉變和預測 (過去·今後8年份),各產品類型詳細趨勢,主要企業·流通管道的市場佔有率,主要的開發中產品的目前臨床實驗情形,近來的資本交易·企業發展的動向,主要企業簡介等相關調查。

第1章 目錄

第2章 簡介

  • 本報告概要
  • 藥物輸送設備市場明細
  • 本報告分析對象市場定義

第3章 德國的藥物輸送設備市場

  • 市場收益額趨勢:以金額為準 (總計15年份)
  • 市場收益額結構:以金額為準
  • 市場收益額:各類別佔有率
  • 市場收益額:各類別佔有率比較 (總計15年份)
  • 市場收益額的實際成果值:以金額為準 (過去8年份)
  • 市場收益額的預測值:以金額為準 (今後8年份)
  • 市場規模趨勢:以數量為準 (總計15年份)
  • 市場規模的實際成果值:以數量為準 (過去8年份)
  • 市場規模的預測值:以數量為準 (今後8年份)
  • 市場收益額佔有率:各企業

第4章 德國中央靜脈導管市場

  • 市場收益額結構:以金額為準
  • 市場收益額:各類別佔有率
  • 市場收益額的實際成果值:以金額為準 (過去8年份)
  • 市場收益額的預測值:以金額為準 (今後8年份)
  • 市場規模的實際成果值:以數量為準 (過去8年份)
  • 市場規模的預測值:以數量為準 (今後8年份)
  • 市場收益額佔有率:各流通管道
  • 市場收益額佔有率:各企業

第5章 德國的輸液系統市場

  • 市場收益額結構:以金額為準
  • 市場收益額:各類別佔有率
  • 市場收益額的實際成果值:以金額為準 (過去8年份)
  • 市場收益額的預測值:以金額為準 (今後8年份)
    • 可攜式輸液幫浦的市場收益額:實際成果值·預測值 (總計15年份)
    • 注射式幫浦的市場收益額:實際成果值·預測值 (總計15年份)
  • 市場規模的實際成果值:以數量為準 (過去8年份)
  • 市場規模的預測值:以數量為準 (今後8年份)
    • 可攜式輸液幫浦的市場規模:實際成果值·預測值 (總計15年份)
    • 注射式幫浦的市場規模:實際成果值·預測值 (總計15年份)
  • 市場收益額佔有率:各流通管道
  • 市場收益額佔有率:各企業

第6章 德國的無針頭注射器市場

  • 市場收益額的實際成果值:以金額為準 (過去8年份)
  • 市場收益額的預測值:以金額為準 (今後8年份)
  • 市場規模的實際成果值:以數量為準 (過去8年份)
  • 市場規模的預測值:以數量為準 (今後8年份)
  • 市場收益額佔有率:各流通管道
  • 市場收益額佔有率:各企業

第7章 德國的定量噴霧吸入器 (MDI) 市場

  • 市場收益額的實際成果值:以金額為準 (過去8年份)
  • 市場收益額的預測值:以金額為準 (今後8年份)
  • 市場規模的實際成果值:以數量為準 (過去8年份)
  • 市場規模的預測值:以數量為準 (今後8年份)
  • 市場收益額佔有率:各流通管道
  • 市場收益額佔有率:各企業

第8章 主要企業簡介:德國的藥物輸送設備市場

  • B. Braun Melsungen AG
    • 企業概要
  • Teleflex Inc
  • GlaxoSmithKline Plc
  • C. R. Bard Inc
  • Edwards Lifesciences Corp
  • AstraZeneca Plc
  • Boehringer Ingelheim GmbH
  • Pfizer Inc
  • Baxter International Inc
  • Merck & Co Inc
  • Becton Dickinson and Co
  • Fresenius Kabi AG
  • Smiths Medical
  • Medtronic Plc
  • Nipro
  • Hospira Inc
  • Terumo Corporation

第9章 藥物輸送設備市場開發中產品

第10章 資本交易環境

  • 企業收購
  • 資產交易
  • 發行公司債券
  • 股票上市
  • 產業聯盟
  • 風險企業融資

第11章 近幾年主要的動向

  • 來自企業的發表 (企業·通訊)
  • 公佈財報
  • 法規·規定相關
  • 其他主要動向
  • 產品新聞
  • 策略·產業計畫

第12章 附錄

圖表一覽

目錄
Product Code: GDMEMC0244DB

GlobalData's new report, "Germany Drug Delivery Devices Market Outlook to 2023", provides key market data on the Germany Drug Delivery Devices market. The report provides value, in millions of US dollars and volume (in units) within market categories - Central Venous Catheters, Needle Free Injections, Infusion Systems and Metered Dose Inhaler Devices.

The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope:

  • Market size and company share data for Drug Delivery Devices market categories - Central Venous Catheters, Needle Free Injections, Infusion Systems and Metered Dose Inhaler Devices.
  • Annualized market revenues (USD million) and volume (units) data for each of the market categories. Data is provided from 2009 to 2016 and forecast to 2023.
  • 2016 company shares and distribution shares data for each of the market categories.
  • Global corporate-level profiles of key companies operating within the Germany Drug Delivery Devices market.
  • Key players covered include GlaxoSmithKline Plc, AstraZeneca Plc, Hospira Inc, Becton Dickinson and Co, Boehringer Ingelheim GmbH, Baxter International Inc, Medtronic plc and others.

Reasons to buy:

  • Develop business strategies by identifying the key market categories poised for strong growth in the future.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market categories expected to register strong growth in the near future.
  • What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. What Is This Report About?
  • 2.2. Drug Delivery Devices Market Segmentation
  • 2.3. Definitions of Markets Covered in the Report

3. Drug Delivery Devices Market, Germany

  • 3.1. Drug Delivery Devices Market, Germany, Revenue ($m), 2009-2023
  • 3.2. Drug Delivery Devices Market, Germany, Revenue Mix ($m), 2016
  • 3.3. Drug Delivery Devices Market, Germany, Category Contribution by Revenue ($m), 2016
  • 3.4. Drug Delivery Devices Market, Germany, Category Comparison by Revenue ($m), 2009-2023
  • 3.5. Drug Delivery Devices Market, Germany, Revenue ($m), 2009-2016
  • 3.6. Drug Delivery Devices Market, Germany, Revenue ($m), 2016-2023
  • 3.7. Drug Delivery Devices Market, Germany, Volume (Units), 2009-2023
  • 3.8. Drug Delivery Devices Market, Germany, Volume (Units), 2009-2016
  • 3.9. Drug Delivery Devices Market, Germany, Volume (Units), 2016-2023
  • 3.10. Drug Delivery Devices Market, Germany, Company Share by Revenue ($m), 2016

4. Central Venous Catheters Market, Germany

  • 4.1. Central Venous Catheters Market, Germany, Revenue Mix ($m), 2016
  • 4.2. Central Venous Catheters Market, Germany, Segment Contribution (%), 2016
  • 4.1. Central Venous Catheters Market, Germany, Revenue ($m), 2009-2016
  • 4.2. Central Venous Catheters Market, Germany, Revenue ($m), 2016-2023
  • 4.3. Central Venous Catheters Market, Germany, Volume (Units), 2009-2016
  • 4.4. Central Venous Catheters Market, Germany, Volume (Units), 2016-2023
  • 4.6. Central Venous Catheters Market, Germany, Distribution Share by Revenue ($m), 2015-2016
  • 4.7. Central Venous Catheters Market, Germany, Company Share by Revenue ($m), 2016

5. Infusion Systems Market, Germany

  • 5.1. Infusion Systems Market, Germany, Revenue Mix ($m), 2016
  • 5.2. Infusion Systems Market, Germany, Segment Contribution (%), 2016
  • 5.3. Infusion Systems Market, Germany, Revenue ($m), 2009-2016
  • 5.4. Infusion Systems Market, Germany, Revenue ($m), 2016-2023
    • 5.4.1. Ambulatory Infusion Pumps Market, Germany, Revenue ($m), by Segment, 2009-2016
    • 5.4.2. Syringe Pumps Market, Germany, Revenue ($m), by Segment, 2009-2016
    • 5.4.3. Ambulatory Infusion Pumps Market, Germany, Revenue ($m), by Segment, 2016-2023
    • 5.4.4. Syringe Pumps Market, Germany, Revenue ($m), by Segment, 2016-2023
  • 5.5. Infusion Systems Market, Germany, Volume (Units), 2009-2016
  • 5.6. Infusion Systems Market, Germany, Volume (Units), 2016-2023
    • 5.6.1. Ambulatory Infusion Pumps Market, Germany, Volume (Units), by Segment, 2009-2016
    • 5.6.2. Syringe Pumps Market, Germany, Volume (Units), by Segment, 2009-2016
    • 5.6.3. Ambulatory Infusion Pumps Market, Germany, Volume (Units), by Segment, 2016-2023
    • 5.6.4. Syringe Pumps Market, Germany, Volume (Units), by Segment, 2016-2023
  • 5.7. Infusion Systems Market, Germany, Distribution Share by Revenue ($m), 2015-2016
  • 5.8. Infusion Systems Market, Germany, Company Share by Revenue ($m), 2016

6. Metered Dose Inhaler Devices Market, Germany

  • 6.1. Metered Dose Inhaler Devices Market, Germany, Revenue ($m), 2009-2016
  • 6.2. Metered Dose Inhaler Devices Market, Germany, Revenue ($m), 2016-2023
  • 6.3. Metered Dose Inhaler Devices Market, Germany, Volume (Units), 2009-2016
  • 6.4. Metered Dose Inhaler Devices Market, Germany, Volume (Units), 2016-2023
  • 6.5. Metered Dose Inhaler Devices Market, Germany, Distribution Share by Revenue ($m), 2015-2016
  • 6.6. Metered Dose Inhaler Devices Market, Germany, Company Share by Revenue ($m), 2016

7. Needle Free Injections Market, Germany

  • 7.1. Needle Free Injections Market, Germany, Revenue ($m), 2009-2016
  • 7.2. Needle Free Injections Market, Germany, Revenue ($m), 2016-2023
  • 7.3. Needle Free Injections Market, Germany, Volume (Units), 2009-2016
  • 7.4. Needle Free Injections Market, Germany, Volume (Units), 2016-2023
  • 7.5. Needle Free Injections Market, Germany, Distribution Share by Revenue ($m), 2015-2016
  • 7.6. Needle Free Injections Market, Germany, Company Share by Revenue ($m), 2016

8. Overview of Key Companies in Germany, Drug Delivery Devices Market

  • 8.1. B. Braun Melsungen AG
    • 8.1.1. Company Overview
  • 8.2. Teleflex Inc
    • 8.2.1. Company Overview
  • 8.3. GlaxoSmithKline Plc
    • 8.3.1. Company Overview
  • 8.4. C. R. Bard Inc
    • 8.4.1. Company Overview
  • 8.5. Edwards Lifesciences Corp
    • 8.5.1. Company Overview
  • 8.6. AstraZeneca Plc
    • 8.6.1. Company Overview
  • 8.7. Boehringer Ingelheim GmbH
    • 8.7.1. Company Overview
  • 8.8. Pfizer Inc
    • 8.8.1. Company Overview
  • 8.9. Baxter International Inc
    • 8.9.1. Company Overview
  • 8.10. Merck & Co Inc
    • 8.10.1. Company Overview
  • 8.11. Becton Dickinson and Co
    • 8.11.1. Company Overview
  • 8.12. Fresenius Kabi AG
    • 8.12.1. Company Overview
  • 8.13. Smiths Medical
    • 8.13.1. Company Overview
  • 8.14. Medtronic Plc
    • 8.14.1. Company Overview
  • 8.15. Nipro Corp
    • 8.15.1. Company Overview
  • 8.16. Hospira Inc
    • 8.16.1. Company Overview
  • 8.17. Terumo Corp
    • 8.17.1. Company Overview

9. Drug Delivery Devices Market Pipeline Products

10. Financial Deals Landscape

  • 10.1. Acquisition
    • 10.1.1. Dietmar Hopp May Sell its Stake in LTS Lohmann Therapie-Systeme
    • 10.1.2. Luye Pharma Acquires Acino and Acino Supply for USD269 Million
  • 10.2. Asset Transactions
    • 10.2.1. ICU Medical Acquires Hospira Infusion Systems Business from Pfizer
  • 10.3. Debt Offerings
    • 10.3.1. Fresenius Raises USD742.5 Million in Private Placement of 0.875% Notes Due 2022
    • 10.3.2. Fresenius Raises USD742.5 Million in Private Placement of 1.5% Notes Due 2024
    • 10.3.3. Fresenius Raises USD742.5 Million in Private Placement of 2.125% Notes Due 2027
    • 10.3.4. Fresenius Raises USD530.4 Million in Private Placement of 3% Notes Due 2032
  • 10.4. Equity Offerings
    • 10.4.1. Magforce Raises USD5.6 Million in Private Placement of Shares
  • 10.5. Partnerships
    • 10.5.1. Alimera Sciences Enters into Licensing Agreement with pSivida
    • 10.5.2. Vetter Pharma International and Microdermics Enter into Agreement
    • 10.5.3. Ferring International and Alrise Biosystems Enter into Co-Development Agreement
    • 10.5.4. Bluegrass Vascular Enters into Partnership with Merit Medical
    • 10.5.5. Aequus Pharma to Enter into Licensing Agreement with Transdermal Research Pharm Labs
    • 10.5.6. Valeant Pharma Enters into Licensing Agreement with EyeGate Pharma
    • 10.5.7. Propeller Health Enters into Agreement with Novartis Pharma
    • 10.5.8. Neuronex Enters Into Licensing Agreement With SK Biopharmaceuticals For DZNS Technology
    • 10.5.9. Pfizer Terminates its Licensing Agreement with pSivida
    • 10.5.10. BioMed X Enters into Agreement with Merck
    • 10.5.11. Bayer Enters into Licensing Agreement with DelSiTech
    • 10.5.12. BioCorRx Enters into Licensing Agreement with Therakine
  • 10.6. Venture Financing
    • 10.6.1. AMW Raises USD6.4 Million in Venture Financing

11. Recent Developments

  • 11.1. Corporate Communications
    • 11.1.1. Jun 29, 2017: Bernhard Kernen named CFO of Raumedic
    • 11.1.2. Jun 27, 2017: NOVALIQ Strengthens Executive Management Team with the Appointment of Gabriela Burian, MD, MPH, as Chief Medical Officer
    • 11.1.3. May 12, 2017: Constantin Birnstiel to Become Head of Group Communications at Merck
    • 11.1.4. Apr 12, 2017: Change in the B. Braun Management Board and the Aesculap Management Board
    • 11.1.5. Apr 05, 2017: New member of the Executive Board appointed
    • 11.1.6. Mar 28, 2017: Vetter's Dr. Claudia Roth is appointed to the Fraunhofer Advisory Board
    • 11.1.7. Feb 22, 2017: Change in the B. Braun Management Board
    • 11.1.8. Feb 07, 2017: Haselmeier Appoints Paul Jansen as Senior Advisor and Member of the Board of Directors
    • 11.1.9. Jan 13, 2017: Fresenius Medical Care Announces Leadership Change in North America
    • 11.1.10. Jan 09, 2017: leon Appoints Pharma Expert Michael Mehler as Chief Executive Officer
    • 11.1.11. Jan 09, 2017: leon-nanodrugs Appoints Pharma Expert Michael Mehler as Chief Executive Officer
    • 11.1.12. Oct 31, 2016: TCT 2016: Orsiro Drug-Eluting Stent Proves Non-Inferiority to Resolute Integrity and Synergy Stents
    • 11.1.13. Sep 23, 2016: Merck Appoints Isabel De Paoli as Chief Strategy Officer
    • 11.1.14. Aug 10, 2016: MagForce announces positive results of 2016 Annual General Meeting
    • 11.1.15. Jul 22, 2016: LTS Lohmann Therapie-Systeme Appoints New Chief TechOps Officer
  • 11.2. Financial Announcements
    • 11.2.1. Jun 30, 2017: MagForce Publishes Financial Results for the Year 2016 and Operative Highlights
    • 11.2.2. May 18, 2017: Merck Continues to Grow Profitably in the First Quarter
    • 11.2.3. Apr 05, 2017: Successful financial year 2016 for Boehringer Ingelheim
    • 11.2.4. Mar 31, 2017: B. Braun continues its sales and earnings growth
    • 11.2.5. Oct 27, 2016: Fresenius: Continued strong sales and earnings growth; Lower end of Group earnings guidance raised
    • 11.2.6. Sep 30, 2016: MagForce Publishes Financial Results for the First Half of 2016 and Operative Highlights
    • 11.2.7. Aug 04, 2016: Merck Lifts Forecast Following Good Second Quarter
    • 11.2.8. Aug 01, 2016: Fresenius Medical Care posts accelerated earnings growth in the 2nd quarter
  • 11.3. Legal And Regulatory
    • 11.3.1. Jan 31, 2017: Fresenius Medical Care reaches agreement on outstanding payments
    • 11.3.2. Dec 13, 2016: TUV Certification for the Bengaluru Facility
    • 11.3.3. Nov 30, 2016: New Vetter data processing center is officially certified
  • 11.4. Other Significant Developments
    • 11.4.1. Jul 12, 2017: Merck Refines Western European Life Science Production Site Network
    • 11.4.2. Jul 12, 2017: Fresenius Medical Care successfully amends and extends its credit agreement, ahead of schedule
    • 11.4.3. Jun 08, 2017: B. Braun is participating in the third edition of the High-Tech Founders Fund
    • 11.4.4. Apr 28, 2017: MEDITE Cancer Diagnostics Announces Reorganization of Germany Operations
    • 11.4.5. Mar 21, 2017: Merck Accelerator Hits New Peak of Applications
    • 11.4.6. Mar 10, 2017: Fresenius Kabi builds new warehouse at Blonie production site
    • 11.4.7. Mar 09, 2017: Merck Generates Record Sales and Continues to Grow Profitably in 2016
    • 11.4.8. Nov 15, 2016: Merck Raises Profit Forecast for 2016 Following Good Third Quarter
    • 11.4.9. Oct 11, 2016: Fresenius Kabi Joins Chicago Health Innovation Incubator MATTER as Newest Strategic Partner
    • 11.4.10. Aug 17, 2016: Fresenius Kabi investing nearly $250 million to expand plant near Chicago
    • 11.4.11. Aug 03, 2016: Boehringer Ingelheim: Growth in all core businesses
    • 11.4.12. Jul 19, 2016: MilliporeSigma Starts Construction on $115 Million Multi-faceted Life Science Campus in Burlington, Massachusetts
  • 11.5. Product News
    • 11.5.1. May 03, 2017: B. Braun Focused on Peripheral Vascular Access & Hazardous Drug Safety at INS
  • 11.6. Strategy And Business Planning
    • 11.6.1. Jul 06, 2017: Fresenius Kabi expands production site in Portugal
    • 11.6.2. Jun 29, 2017: Merck Expands Packaging Capacity at Swiss Biotech Manufacturing Site of Aubonne
    • 11.6.3. Jun 20, 2017: Merck Ventures Creates New Immuno-Oncology Company iOnctura
    • 11.6.4. Jun 08, 2017: Fresenius Medical Care sees excellent prospects for further growth and launches a new Global Efficiency Program at its Capital Markets Day 2017
    • 11.6.5. May 16, 2017: Merck: Optimizing the Further Development of the Darmstadt Site
    • 11.6.6. Apr 20, 2017: Merck Provides Upgraded Manufacturing Capabilities to BioInvent with Single-use Mobius Bioreactors
    • 11.6.7. Feb 16, 2017: GSK and EMBL have signed an agreement to enhance understanding of disease and drug mechanisms
    • 11.6.8. Nov 22, 2016: HELIOS lays foundation stone for new hospital building in Wiesbaden
    • 11.6.9. Oct 13, 2016: Merck Sets its Sights on 2018 and Outlines Future Strategic Roadmap

12. Appendix

  • 12.1. Research Methodology
    • 12.1.1. Coverage
    • 12.1.2. Secondary Research
    • 12.1.3. Primary Research
    • 12.1.4. Company Share Analysis
    • 12.1.5. Distribution Share Analysis
    • 12.1.6. Benchmarking
  • 12.2. GlobalData Consulting
  • 12.3. Contact Us
  • 12.4. Disclaimer

List of Tables

  • Table 1: Drug Delivery Devices Market, Germany, Revenue ($m), USD Constant, 2009-2023
  • Table 2: Drug Delivery Devices Market, Germany, Category Contribution by Revenue ($m), 2016
  • Table 3: Drug Delivery Devices Market, Germany, Category Comparison by Revenue ($m), 2009-2023
  • Table 4: Drug Delivery Devices Market, Germany, Revenue ($m), USD Constant, Historic, 2009-2016
  • Table 5: Drug Delivery Devices Market, Germany, Revenue ($m), USD Constant, Forecast, 2016-2023
  • Table 6: Drug Delivery Devices Market, Germany, Volume (Units), 2009-2023
  • Table 7: Drug Delivery Devices Market, Germany, Volume (Units), Historic, 2009-2016
  • Table 8: Drug Delivery Devices Market, Germany, Volume (Units), Forecast, 2016-2023
  • Table 9: Drug Delivery Devices Market, Germany, Company Share by Revenue ($m), USD Constant, 2016
  • Table 10: Central Venous Catheters Market, Germany, Segment Contribution (%), 2016
  • Table 11: Central Venous Catheters Market, Germany, Revenue ($m), USD Constant, Historic, 2009-2016
  • Table 12: Central Venous Catheters Market, Germany, Revenue ($m), USD Constant, Forecast, 2016-2023
  • Table 13: Central Venous Catheters Market, Germany, Volume (Units), Historic, 2009-2016
  • Table 14: Central Venous Catheters Market, Germany, Volume (Units), Forecast, 2016-2023
  • Table 15: Central Venous Catheters Market, Germany, Distribution Share by Revenue ($m), USD Constant, 2015-2016
  • Table 16: Central Venous Catheters Market, Germany, Company Share by Revenue ($m), USD Constant, 2016
  • Table 17: Infusion Systems Market, Germany, Segment Contribution (%), 2016
  • Table 18: Infusion Systems Market, Germany, Revenue ($m), USD Constant, Historic, 2009-2016
  • Table 19: Infusion Systems Market, Germany, Revenue ($m), USD Constant, Forecast, 2016-2023
  • Table 20: Ambulatory Infusion Pumps Market, Germany, Revenue ($m), USD Constant, Historic, 2009-2016
  • Table 21: Syringe Pumps Market, Germany, Revenue ($m), USD Constant, Historic, 2009-2016
  • Table 22: Ambulatory Infusion Pumps Market, Germany, Revenue ($m), USD Constant, Forecast, 2016-2023
  • Table 23: Syringe Pumps Market, Germany, Revenue ($m), USD Constant, Forecast, 2016-2023
  • Table 24: Infusion Systems Market, Germany, Volume (Units), Historic, 2009-2016
  • Table 25: Infusion Systems Market, Germany, Volume (Units), Forecast, 2016-2023
  • Table 26: Ambulatory Infusion Pumps Market, Germany, Volume (Units), Historic, 2009-2016
  • Table 27: Syringe Pumps Market, Germany, Volume (Units), Historic, 2009-2016
  • Table 28: Ambulatory Infusion Pumps Market, Germany, Volume (Units), Forecast, 2016-2023
  • Table 29: Syringe Pumps Market, Germany, Volume (Units), Forecast, 2016-2023
  • Table 30: Infusion Systems Market, Germany, Distribution Share by Revenue ($m), USD Constant, 2015-2016
  • Table 31: Infusion Systems Market, Germany, Company Share by Revenue ($m), USD Constant, 2016
  • Table 32: Metered Dose Inhaler Devices Market, Germany, Revenue ($m), USD Constant, Historic, 2009-2016
  • Table 33: Metered Dose Inhaler Devices Market, Germany, Revenue ($m), USD Constant, Forecast, 2016-2023
  • Table 34: Metered Dose Inhaler Devices Market, Germany, Volume (Units), Historic, 2009-2016
  • Table 35: Metered Dose Inhaler Devices Market, Germany, Volume (Units), Forecast, 2016-2023
  • Table 36: Metered Dose Inhaler Devices Market, Germany, Distribution Share by Revenue ($m), USD Constant, 2015-2016
  • Table 37: Metered Dose Inhaler Devices Market, Germany, Company Share by Revenue ($m), USD Constant, 2016
  • Table 38: Needle Free Injections Market, Germany, Revenue ($m), USD Constant, Historic, 2009-2016
  • Table 39: Needle Free Injections Market, Germany, Revenue ($m), USD Constant, Forecast, 2016-2023
  • Table 40: Needle Free Injections Market, Germany, Volume (Units), Historic, 2009-2016
  • Table 41: Needle Free Injections Market, Germany, Volume (Units), Forecast, 2016-2023
  • Table 42: Needle Free Injections Market, Germany, Distribution Share by Revenue ($m), USD Constant, 2015-2016
  • Table 43: Needle Free Injections Market, Germany, Company Share by Revenue ($m), USD Constant, 2016
  • Table 44: Drug Delivery Devices Market Pipeline Products
  • Table 45: Dietmar Hopp May Sell its Stake in LTS Lohmann Therapie-Systeme
  • Table 46: Luye Pharma Acquires Acino and Acino Supply for USD269 Million
  • Table 47: ICU Medical Acquires Hospira Infusion Systems Business from Pfizer
  • Table 48: Fresenius Raises USD742.5 Million in Private Placement of 0.875% Notes Due 2022
  • Table 49: Fresenius Raises USD742.5 Million in Private Placement of 1.5% Notes Due 2024
  • Table 50: Fresenius Raises USD742.5 Million in Private Placement of 2.125% Notes Due 2027
  • Table 51: Fresenius Raises USD530.4 Million in Private Placement of 3% Notes Due 2032
  • Table 52: Magforce Raises USD5.6 Million in Private Placement of Shares
  • Table 53: Alimera Sciences Enters into Licensing Agreement with pSivida
  • Table 54: Vetter Pharma International and Microdermics Enter into Agreement
  • Table 55: Ferring International and Alrise Biosystems Enter into Co-Development Agreement
  • Table 56: Bluegrass Vascular Enters into Partnership with Merit Medical
  • Table 57: Aequus Pharma to Enter into Licensing Agreement with Transdermal Research Pharm Labs
  • Table 58: Valeant Pharma Enters into Licensing Agreement with EyeGate Pharma
  • Table 59: Propeller Health Enters into Agreement with Novartis Pharma
  • Table 60: Neuronex Enters Into Licensing Agreement With SK Biopharmaceuticals For DZNS Technology
  • Table 61: Pfizer Terminates its Licensing Agreement with pSivida
  • Table 62: BioMed X Enters into Agreement with Merck
  • Table 63: Bayer Enters into Licensing Agreement with DelSiTech
  • Table 64: BioCorRx Enters into Licensing Agreement with Therakine
  • Table 65: AMW Raises USD6.4 Million in Venture Financing

List of Figures

  • Figure 1: Drug Delivery Devices Market, Germany, Revenue ($m), USD Constant, 2009-2023
  • Figure 2: Drug Delivery Devices Market, Germany, Revenue Mix ($m), 2016
  • Figure 3: Drug Delivery Devices Market, Germany, Category Contribution (%), 2016
  • Figure 4: Drug Delivery Devices Market, Germany, Category Comparison by Revenue ($m), 2009-2023
  • Figure 5: Drug Delivery Devices Market, Germany, Revenue ($m), USD Constant, Historic, 2009-2016
  • Figure 6: Drug Delivery Devices Market, Germany, Revenue ($m), USD Constant, Forecast, 2016-2023
  • Figure 7: Drug Delivery Devices Market, Germany, Volume (Units), 2009-2023
  • Figure 8: Drug Delivery Devices Market, Germany, Volume (Units), Historic, 2009-2016
  • Figure 9: Drug Delivery Devices Market, Germany, Volume (Units), Forecast, 2016-2023
  • Figure 10: Drug Delivery Devices Market, Germany, Company Share (%) 2016
  • Figure 11: Central Venous Catheters Market, Germany, Revenue Mix ($m), 2016
  • Figure 12: Central Venous Catheters Market, Germany, Segment Contribution (%), 2016
  • Figure 13: Central Venous Catheters Market, Germany, Revenue ($m), USD Constant, Historic, 2009-2016
  • Figure 14: Central Venous Catheters Market, Germany, Revenue ($m), USD Constant, Forecast, 2016-2023
  • Figure 15: Central Venous Catheters Market, Germany, Volume (Units), Historic, 2009-2016
  • Figure 16: Central Venous Catheters Market, Germany, Volume (Units), Forecast, 2016-2023
  • Figure 17: Central Venous Catheters Market, Germany, Company Share (%) 2016
  • Figure 18: Infusion Systems Market, Germany, Revenue Mix ($m), 2016
  • Figure 19: Infusion Systems Market, Germany, Segment Contribution (%), 2016
  • Figure 20: Infusion Systems Market, Germany, Revenue ($m), USD Constant, Historic, 2009-2016
  • Figure 21: Infusion Systems Market, Germany, Revenue ($m), USD Constant, Forecast, 2016-2023
  • Figure 22: Ambulatory Infusion Pumps Market, Germany, Revenue ($m), USD Constant, Historic, 2009-2016
  • Figure 23: Syringe Pumps Market, Germany, Revenue ($m), USD Constant, Historic, 2009-2016
  • Figure 24: Ambulatory Infusion Pumps Market, Germany, Revenue ($m), USD Constant, Forecast, 2016-2023
  • Figure 25: Syringe Pumps Market, Germany, Revenue ($m), USD Constant, Forecast, 2016-2023
  • Figure 26: Infusion Systems Market, Germany, Volume (Units), Historic, 2009-2016
  • Figure 27: Infusion Systems Market, Germany, Volume (Units), Forecast, 2016-2023
  • Figure 28: Ambulatory Infusion Pumps Market, Germany, Volume (Units), Historic, 2009-2016
  • Figure 29: Syringe Pumps Market, Germany, Volume (Units), Historic, 2009-2016
  • Figure 30: Ambulatory Infusion Pumps Market, Germany, Volume (Units), Forecast, 2016-2023
  • Figure 31: Syringe Pumps Market, Germany, Volume (Units), Forecast, 2016-2023
  • Figure 32: Infusion Systems Market, Germany, Company Share (%) 2016
  • Figure 33: Metered Dose Inhaler Devices Market, Germany, Revenue ($m), USD Constant, Historic, 2009-2016
  • Figure 34: Metered Dose Inhaler Devices Market, Germany, Revenue ($m), USD Constant, Forecast, 2016-2023
  • Figure 35: Metered Dose Inhaler Devices Market, Germany, Volume (Units), Historic, 2009-2016
  • Figure 36: Metered Dose Inhaler Devices Market, Germany, Volume (Units), Forecast, 2016-2023
  • Figure 37: Metered Dose Inhaler Devices Market, Germany, Company Share (%) 2016
  • Figure 38: Needle Free Injections Market, Germany, Revenue ($m), USD Constant, Historic, 2009-2016
  • Figure 39: Needle Free Injections Market, Germany, Revenue ($m), USD Constant, Forecast, 2016-2023
  • Figure 40: Needle Free Injections Market, Germany, Volume (Units), Historic, 2009-2016
  • Figure 41: Needle Free Injections Market, Germany, Volume (Units), Forecast, 2016-2023
  • Figure 42: Needle Free Injections Market, Germany, Company Share (%) 2016
Back to Top